Cancer Care for Older Adults – An Introduction

Cancer Care for Older Adults – An Introduction

[music] Geriatric oncology is what is emerging as a subspecialty of cancer care, really focused on older patients. And why it’s important is older patients are very variable as far as their healthcare status when they get cancer. And it’s really a challenge to know how to best care for them. So, our branch ofRead More Cancer Care for Older Adults – An Introduction

Immunotherapy Side Effects Guidelines

Immunotherapy Side Effects Guidelines

Immunotherapy with immune checkpoint inhibitors has revolutionized treatment for many different types of cancer by unleashing the body’s immune system to attack cancer. These therapies can send even the most hard to treat cancers into lasting remission. But these treatments also come with unique side effects that can effect multiple organs in the body, andRead More Immunotherapy Side Effects Guidelines

HRQoL of Pembrolizumab vs. Chemotherapy for Previously Treated…

HRQoL of Pembrolizumab vs. Chemotherapy for Previously Treated…

Hello. I’m Ronald de Wit. I’m a medical oncologist from the Erasmus Medical Center Cancer Institute in the Netherlands, Rotterdam. And I was involved in the KEYNOTE-045 Study. The KEYNOTE-045 Study was a randomized phase three trial investigating the checkpoint inhibitor pembrolizumab versus investigator-choice of chemotherapy, vinflunine, docetaxel, or paclitaxel in patients with metastatic bladderRead More HRQoL of Pembrolizumab vs. Chemotherapy for Previously Treated…

Optimizing Chemotherapy for Frail and Elderly Patients With Advanced Gastroesophageal Cancer

Optimizing Chemotherapy for Frail and Elderly Patients With Advanced Gastroesophageal Cancer

>>OK, so we’re talking about gastroesophageal cancer and a study that ASCO has chosen to highlight. Why are you interested in this study?>>I love this study. A perennial problem in cancer clinical trials is that the people we include in our trials are the fit, healthy triathlete cancer patients, and we leave out the largeRead More Optimizing Chemotherapy for Frail and Elderly Patients With Advanced Gastroesophageal Cancer

Ovarian Cancer Tumor-Stroma Proportion and Resistance to Platinum Chemotherapy

Ovarian Cancer Tumor-Stroma Proportion and Resistance to Platinum Chemotherapy

>>You’re publishing a paper in JAMA Oncology about ovarian cancer and chemotherapy. So tell us about this paper.>>This was a very exciting study, although it was very small, only in 24 patients. But the investigators question whether the tumor-stroma proportion could predict those patients who didn’t respond to chemotherapy. So they divided the patients upRead More Ovarian Cancer Tumor-Stroma Proportion and Resistance to Platinum Chemotherapy

New Research on Chemotherapy for Colon Cancer

New Research on Chemotherapy for Colon Cancer

[music] You know, there are a number of themes in oncology. You’ve heard about precision medicine and immunotherapy, but 1 that’s very important that we’ve been studying now for decades is, do we need to over-treat people to make sure we give them the right treatment. And when our field started, that was sort ofRead More New Research on Chemotherapy for Colon Cancer